These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4036271)

  • 1. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans.
    Niklasson B; Peters CJ; Bengtsson E; Norrby E
    Vaccine; 1985 Jun; 3(2):123-7. PubMed ID: 4036271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serological survey of Rift Valley fever antibodies in the northern Sinai.
    Kark JD; Aynor Y; Ben Mordechai Y; Ron-Kuper N; Peleg BA; Peters CJ
    Trans R Soc Trop Med Hyg; 1982; 76(4):427-30. PubMed ID: 6926758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological tests for detecting Rift Valley fever viral antibodies in sheep from the Nile Delta.
    Scott RM; Feinsod FM; Allam IH; Ksiazek TG; Peters CJ; Botros BA; Darwish MA
    J Clin Microbiol; 1986 Oct; 24(4):612-4. PubMed ID: 3533977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up.
    Kark JD; Aynor Y; Peters CJ
    Am J Epidemiol; 1982 Nov; 116(5):808-20. PubMed ID: 6890766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.
    Morrill JC; Laughlin RC; Lokugamage N; Pugh R; Sbrana E; Weise WJ; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Jan; 31(3):559-65. PubMed ID: 23153443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection.
    Kark JD; Aynor Y; Peters CJ
    Vaccine; 1985 Jun; 3(2):117-22. PubMed ID: 4036270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius).
    Davies FG; Koros J; Mbugua H
    J Hyg (Lond); 1985 Apr; 94(2):241-4. PubMed ID: 3989285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials.
    Meadors GF; Gibbs PH; Peters CJ
    Vaccine; 1986 Sep; 4(3):179-84. PubMed ID: 3532605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.
    Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Erasmus BJ; Barnard BJ
    J Hyg (Lond); 1986 Oct; 97(2):317-29. PubMed ID: 3537118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase immunosorbent technique for rapid detection of Rift Valley fever virus immunoglobulin M by hemagglutination inhibition.
    Soliman AK; Botros BA; Morrill JC
    J Clin Microbiol; 1988 Sep; 26(9):1913-5. PubMed ID: 3053781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rift Valley fever surveillance in mobile sheep flocks in the Nile Delta.
    Allam IH; Feinsod FM; Scott RM; Peters CJ; Saah AJ; Ghaffar SA; el Said S; Darwish MA
    Am J Trop Med Hyg; 1986 Sep; 35(5):1055-60. PubMed ID: 3766852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.
    Pittman PR; Liu CT; Cannon TL; Makuch RS; Mangiafico JA; Gibbs PH; Peters CJ
    Vaccine; 1999 Aug; 18(1-2):181-9. PubMed ID: 10501248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine.
    Yedloutschnig RJ; Dardiri AH; Walker JS; Peters CJ; Eddy GA
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):253-60. PubMed ID: 298921
    [No Abstract]   [Full Text] [Related]  

  • 20. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
    Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
    Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.